{
    "clinical_study": {
        "@rank": "75533", 
        "arm_group": [
            {
                "arm_group_label": "Vitamin D3", 
                "arm_group_type": "Experimental", 
                "description": "Vitamin D3, Cholecalciferol, 5000IU po qday for 12 weeks"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "methylcellulose po qday for 12weeks"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to whether vitamin d supplementation in those with low levels\n      may reduce depression symptoms in people experiencing bipolar depression."
        }, 
        "brief_title": "Vitamin D Supplementation for Bipolar Depression", 
        "condition": [
            "Bipolar Disorder", 
            "Bipolar Depression"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Bipolar Disorder", 
                "Depression", 
                "Depressive Disorder"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Adults >35years old\n\n          -  Bipolar disorder (I,II or NOS),\n\n          -  MADRS Score>7 (mild),\n\n          -  25(OH)D level <30ng/ml (insufficient).\n\n          -  able to take the prescribed vitamin D by mouth\n\n        Exclusion Criteria:\n\n        Systemic diseases such as:\n\n          -  liver and kidney diseases,\n\n          -  known parathyroid disorder,\n\n          -  disorders of vitamin D metabolism,\n\n          -  taking vitamin D replacement therapy,\n\n          -  fat digestion disorder,\n\n          -  diabetes mellitus,\n\n          -  gi surgery\n\n          -  If the serum calcium in the range 2.50-2.55 mmol L, inclusion required a serum PTH\n             below 5.0 pmol L-acute psychiatric urgency:\n\n          -  active suicidality,\n\n          -  acute psychosis,\n\n          -  active substance use<6mo or\n\n          -  pregnant or nursing females"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "35 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 17, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01884844", 
            "org_study_id": "NARSADYI13-15"
        }, 
        "intervention": [
            {
                "arm_group_label": "Vitamin D3", 
                "intervention_name": "Vitamin D3, Cholecalciferol", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Cholecalciferol", 
                "Vitamin D", 
                "Ergocalciferols", 
                "Vitamins"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "lastchanged_date": "January 6, 2014", 
        "location": [
            {
                "contact": {
                    "email": "Jessica.Penny@umassmed.edu", 
                    "last_name": "Jessica Penny, BA", 
                    "phone": "508-334-7352"
                }, 
                "facility": {
                    "address": {
                        "city": "Worcester", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "01605"
                    }, 
                    "name": "University of Massachusetts School of Medicine"
                }, 
                "investigator": {
                    "last_name": "Wendy Marsh, MD, Msc", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "Jessica.penny@umassmed.edu", 
                    "last_name": "Jessica Penny", 
                    "phone": "508-334-7352"
                }, 
                "facility": {
                    "address": {
                        "city": "Worcester", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "01604"
                    }, 
                    "name": "University of Massachusettes"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Randomized Double-Blind Placebo-Controlled Pilot Study of Vitamin D Supplementation for the Treatment of Bipolar Depression", 
        "overall_official": {
            "affiliation": "University of Massachusetts, Worcester", 
            "last_name": "Wendy Marsh, MD MSc", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Change in Montgomery-\u00c5sberg Depression Rating Scale", 
            "safety_issue": "No", 
            "time_frame": "baseline, every two weeks and at 12 week completion"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01884844"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Massachusetts, Worcester", 
            "investigator_full_name": "Wendy Marsh", 
            "investigator_title": "Assistant Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "University of Massachusetts, Worcester", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Massachusetts, Worcester", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}